Noel Ongpauco

[Noel Ongpauco @NoelHST440]

Among the other possible consequences of polypharmacy, there exists the possibility of multi-drug resistant bacteria spreading. If having several diseases at once requires multiple medicines, is this a case where benefits outweigh the harms? #HST440 https://t.co/fpXC4Dsob4

[Noel Ongpauco @NoelHST440]

Interesting article - especially how the author mentions "inevitable polypharmacy". If not the fault of doctors, then what can be done to avoid such a practice when unnecessary? #HST440 https://t.co/3Eg8FWxe9e

[Noel Ongpauco @NoelHST440]

This article has a great discussion on over-medicalization and some of its consequences. This phenomenon seems highly advantageous to pharmaceutical companies - and they are most likely contributing to it. #HST440 https://t.co/411zzr05iy

[Noel Ongpauco @NoelHST440]

Interesting reading regarding a survey about direct-to-consumer advertising. How might advertising laws affect this kind of marketing across different jurisdictions or countries? #HST440 https://t.co/OpGZPiBtLB

[Noel Ongpauco @NoelHST440]

Sismondo makes a compelling and surprising argument about how pharmaceutical companies act as ghosts - and how they have a strong hand in the production and dissemination of medical knowledge. Is there a way to separate or combat industry influence? #HST440

[Noel Ongpauco @NoelHST440]

This article, while dated, illustrates just how daunting it can be to confront companies with pockets this deep. Is there a way to curb the effects of pharmaceutical lobbying and influence on doctors? #HST440
https://t.co/Ywzii93Aq9

[Noel Ongpauco @NoelHST440]

https://t.co/MW4Q7vPGiR

[Noel Ongpauco @NoelHST440]

As we’ve learned in the movie, pharmaceutical companies treasure this industry - doing things such as unnecessarily medicalizing conditions to establish lucrative markets. Companies are willing to duel it out in court to protect their profits - what is the solution? #HST440